tirzepatide side effects migraine Does Cause Headaches? 6 Ways to Manage Them Mounjaro Side Effects | Dealing

Mazdutide, still in testing, shows promise with up to 15%

While Mounjaro (tirzepatide) was originally approved for Type 2 diabetes, Zepbound (tirzepatide) is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30 or above) or overweight (BMI 27 or above) with at least one weight-related condition such as hypertension, high cholesterol, or sleep apnea

The incidence of hypoglycemia for participants treated with tirzepatide for the overall population and the older participants without obesity subgroup is summarized in Table 4

those regimens require clinical dose adjustment and monitoring

Blood pressure and lipid profiles that improved during weight loss may also deteriorate as weight returns